ProfessorDavidCarling

Hope D, Hinds C, Lopes T, et al.Hope D, Hinds C, Lopes T, Vincent M, Shrewsbury J, Yu A, Davies I, Scott R, Jones B, Murphy K, Minnion J, Sardini A, Carling D, Lutz T, Bloom S, Tan T, Owen B close, 2022, Hypoaminoacidemia underpins glucagon-mediated energy expenditure and weight loss, Cell Reports Medicine, Vol:3, ISSN:2666-3791

• DOI
• Open Access Link

Carling D, 2022, Inhibiting lysosomal aldolase: a magic bullet for AMPK activation in treating metabolic disease?, Life Metabolism

• DOI

McGlone ER, Dunsterville C, Carling D, et al.McGlone ER, Dunsterville C, Carling D, tomas A, Bloom S, Tan T, Jones B close, 2022, Hepatocyte cholesterol content modulates glucagon receptor signalling, Molecular Metabolism, Vol:63, ISSN:2212-8778

• DOI
• Publisher Web Link
• Open Access Link

Widjaja AA, Viswanathan S, Wei Ting JG, et al.Widjaja AA, Viswanathan S, Wei Ting JG, Tan J, Shekeran SG, Carling D, Lim W-W, Cook SA close, 2022, IL11 stimulates ERK/P90RSK to inhibit LKB1/AMPK and activate mTOR initiating a mesenchymal program in stromal, epithelial, and cancer cells, Iscience, Vol:25, ISSN:2589-0042

• DOI
• Author Web Link
• Open Access Link

Kabir L, Maughan R, Paschalaki K, et al.Kabir L, Maughan R, Paschalaki K, Randi A, Carling D, Arachchillage D, Mason J, Pericleous C close, 2022, Evidence for Mitochondrial Dysfunction in Blood-derived Endothelial Colony Forming Cells Isolated from Patients with Antiphospholipid Syndrome, WILEY, Pages:4515-4516, ISSN:2326-5191

• Author Web Link